Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Conditions
Advanced Malignant Solid Neoplasm · Clinical Stage III Gastroesophageal Junction Adenocarcinoma · Clinical Stage IV Gastroesophageal Junction Adenocarcinoma · Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma · Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma A · Locally Advanced Colorectal Carcinoma · Locally Advanced Gastroesophageal Junction Adenocarcinoma · Metastatic Colorectal Adenocarcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Pathologic Stage III Gastroesophageal Junction Adenocarcinoma · Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma · Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma · Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma · Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma · Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma · Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Stage III Colorectal Cancer AJCC v8 · Stage IIIA Colorectal Cancer AJCC v8 · Stage IIIB Colorectal Cancer AJCC v8 · Stage IIIC Colorectal Cancer AJCC v8 · Stage IV Colorectal Cancer AJCC v8 · Stage IVA Colorectal Cancer AJCC v8 · Stage IVB Colorectal Cancer AJCC v8 · Stage IVC Colorectal Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Study coordinator (Christos Fountzilas, MD)
Study leads
Christos Fountzilas, MD
Principal Investigator
Roswell Park Cancer Institute